On March 3, 2026, the CoMPaSS-NMD project hosted a landmark event at TECNALIA Research & Innovation in Donostia-San Sebastián, also accessible globally via a live stream.

The event, “Ethics and Regulation in AI for Health,” arrived at a critical juncture as the European healthcare sector navigates the implementation of the EU AI Act and the development of the European Health Data Space (EHDS).

Focusing on Responsible Innovation

The CoMPaSS-NMD initiative is currently developing AI-based methods to classify hereditary neuromuscular diseases by integrating complex genetic, imaging, and clinical data. This event will dive deep into the “how” of this process—ensuring that these diagnostic tools are transparent, accountable, and human-centric.

Expert Insights

The program featured three of the field’s most prominent voices:

  • Dr. Iñigo de Miguel Beriain: A leading authority on Law and the Human Genome.

  • Dr. Guillermo Lazcoz Moratinos: Expert in legal frameworks for medical research.

  • Dr. Gorka Epelde: Specialist in health data coordination and ecosystems.

Who attended?

This event was designed for researchers, healthcare professionals, data scientists, and policymakers who are interested in:

  • The impact of the EU AI Act on clinical research.

  • GDPR compliance and secondary use of personal health data.

  • Overcoming technical and ethical barriers in health data spaces.